Advancement of biomarker discovery and validation through the HUPO plasma proteome project

Disease Markers

Volumn 20, Issue 3, 2004, Pages 131-134

  Omenn, Gilbert S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Biomarkers; Human proteome organization (HUPO); Plasma proteome; Protein databases data repository; Reference specimens

Indexed keywords

PROTEOME;

BLOOD SAMPLING; DATA BASE; DISEASE MARKER; EPIDEMIOLOGICAL DATA; FRACTIONATION; INTERNATIONAL COOPERATION; LABORATORY DIAGNOSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; REVIEW; STANDARDIZATION; TECHNOLOGY; VALIDATION PROCESS;

EID: 4744342860     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/579363     Document Type: Review

References (11)

1. R. Aebersold and M. Mann, Mass spectrometry-based proteomics, Nature 422 (2003), 198-207.
2. S. Hanash, Disease proteomics, Nature 422 (2003), 226-232.
3. M. Tyers and M. Mann, From genomics to proteomics, Nature 422 (2003), 193-197.
4. S. Srivastava and R. Gopal-Srivastava, Biomarkers in cancer screening: a public health perspective, J Nutr 132 (2002), 2471S-2475S.
5. S. Hanash and J.E. Celis, The Human Proteome Organization: a mission to advance proteome knowledge, Mol Cell Proteomics 1.6 (2002), 413-414.
6. J.N. Adkins, S.M. Varnum, K.J. Auberry, R.J. Moore, N.H. Angell et al., Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry, Mol Cell Proteomics 1.12. (2002), 947-955.
7. R. Pieper, C.L. Gatlin, A.J. Makusky, P.S. Russo, C.R. Schatz et al., The human serum proteome: display of nearly 3700 chromatographically separated prtoein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins, Proteomics 3 (2003), 1345-1364.
8. N.L. Anderson, M. Polanski, R. Pieper, T. Gatlin, R.S. Tirumalai et al., The human plasma proteome: A non-redundant list developed by combination of four separate sources, Mol Cell Proteomics 3.4 (2004) 311-326.
9. E. Petricoin and L. Liotta, Clinical proteomics: application at the bedside, Contrib Nephrol 141 (2004), 93-103.
10. N.L. Anderson and N.G. Anderson, The human plasma proteome: history, character, and diagnostic prospects, Mol Cell Proteomics 1.11 (2002), 845-867.
11. L. Zhang, W. Yu, T. He, J. Yu, R.E. Caffrey et al., Contribution of human alpha-depletion 1,2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor, Science 298 (2002), 995-1000.